Grifols | GRFS - Ebit





Ebit تغيير تاريخ
Alaunos Therapeutics USD -1.01M 175K 2026-03
Arca Biopharma USD -36.43M 2M 2026-03
aTyr Pharma USD -121.47K 24.59M 2026-03
Bio Path USD -297K 191K 2026-03
Brainstorm Cell Therapeutics USD -2.05M 1000 2026-03
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cara Therapeutics USD -7.05M 1.11M 2026-03
GlaxoSmithKline GBP 2.6B 312M 2026-06
Grifols EUR 320.55M 91.01M 2025-12
Immunic USD -23.33M 2.67M 2025-12
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
TherapeuticsMD USD -1.77M 699K 2023-09